Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Capital Employed: 2013-2025

Historic Return on Capital Employed for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to -0.77%.

  • Fortress Biotech's Return on Capital Employed rose 84.00% to -0.77% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.77%, marking a year-over-year increase of 84.00%. This contributed to the annual value of -1.31% for FY2024, which is 33.00% down from last year.
  • As of Q3 2025, Fortress Biotech's Return on Capital Employed stood at -0.77%, which was up 18.35% from -0.94% recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Return on Capital Employed registered a high of -0.33% during Q1 2021, and its lowest value of -2.60% during Q3 2023.
  • For the 3-year period, Fortress Biotech's Return on Capital Employed averaged around -1.56%, with its median value being -1.53% (2024).
  • As far as peak fluctuations go, Fortress Biotech's Return on Capital Employed slumped by 171bps in 2023, and later surged by 106bps in 2024.
  • Quarterly analysis of 5 years shows Fortress Biotech's Return on Capital Employed stood at -0.61% in 2021, then tumbled by 51bps to -1.12% in 2022, then plummeted by 80bps to -1.92% in 2023, then rose by 20bps to -1.72% in 2024, then skyrocketed by 84bps to -0.77% in 2025.
  • Its Return on Capital Employed stands at -0.77% for Q3 2025, versus -0.94% for Q2 2025 and -1.10% for Q1 2025.